Written by Ben Stevens and Sarah Sinclair. You can read Part 1 here. Growing demand for medical cannabis across Europe Medical cannabis demand across Europe has seen substantial growth, particularly following the regulatory changes in Germany. Ukraine’s Health Minister, Viktor Liashko, visited Germany this year as [...]
Written by Ben Stevens and Sarah Sinclair. 2024 has been a dramatic year for the global cannabis industry, seeing both historic steps forward and concerning regressions in both attitudes and policy. It was a year dominated by elections, with around half of the world’s population [...]
In a new study researchers explored whether CBD can reduce scan-related anxiety in patients with advanced breast cancer. The findings showed that while CBD did not significantly change scan-related anxiety when compared to a placebo, it was safe and resulted in significantly lower overall anxiety levels [...]
Via Business of Cannabis French patient associations have warned that medical cannabis patients could soon face a disruption in treatment as its long-running experiment comes to an end with no next steps in place. The French Society for the Study and Treatment of Pain (SFETD) issued [...]
Data from a federally funded survey has found that cannabis use amongst teens in the USA is at its lowest since the first states began to legalise adult access to the drug in 2012. The annual Monitoring the Future (MTF) Survey, which is supported by the [...]
From April 2025, Dutch coffee shops will only be permitted to sell regulated cannabis products, as the next phase of the country’s adult-use pilot gets underway. One year on from the launch of the Netherlands’ Closed Coffee Shop Chain Experiment, regulators have set a fixed date [...]
A survey by Health Canada, the government body responsible for regulating the Canadian cannabis market, has shown that the number of people buying cannabis from illegal sources has dropped to just 3%. The annual Canadian Cannabis Survey aims to give researchers important information about the way [...]
Jazz Pharmaceuticals has shared new data to support the efficacy of Epidiolex in patients with tuberous sclerosis complex (TSC). Research shared at the American Epilepsy Society (AES) 2024 Annual Meeting held from 6-10 December in Los Angeles, California supports the use of Epidiolex in the treatment [...]
The United Nations (UN) High Commissioner for Human Rights, Volker Türk, has called for world leaders to treat drug use as a health issue after declaring that the “war on drugs has failed, completely and utterly”. Türk made the statement at the Dealing with Drugs II [...]
MAPS (Multidisciplinary Association for Psychedelic Studies) has secured FDA clearance to conduct a clinical trial examining the use of smoked cannabis for the treatment of PTSD symptoms among veterans. After three years of negotiation, the FDA has given MAPS the green light to carry out a [...]
Via Business of Cannabis In a long-awaited and major step forward for the UK’s CBD sector, the regulator has announced a new roadmap that could see the first products given official approval by Spring next year. While this announcement comes nearly seven years after the novel [...]
Teens who believe their parents use cannabis are more likely to hold favourable attitudes toward the drug and to consider trying it themselves, according to new research. The study, published in the peer-reviewed Journal of Child and Family Studies, also showed that the closeness of the [...]
Thousands more doctors in the Czech Republic will soon be permitted to prescribe medical cannabis under a new decree published by the Ministry of Health. From April 2025, the country’s 5,000 general practitioners will be permitted to prescribe medical cannabis to patients with chronic pain, following [...]
A poll carried out for a UK-based think-tank has found that 66% of police officers believe that the use of cannabis is either ignored or dealt with so lightly that it is in effect ‘decriminalised’. The anti-drug, Tory-linked think tank The Centre for Social Justice commissioned [...]
Via Business of Cannabis UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis research in Europe, announcing the launch of two more major trials using its proprietary compounds. Last month, Business of Cannabis reported that two long-awaited NHS clinical trials to [...]
Researchers from the Centre for Reproductive Health at the University of Edinburgh have co-authored a new review paper highlighting the potential of CBD in the treatment of endometriosis. The new paper, published in the top-ranking journal Trends in Pharmacological Science (TIPS), finds that CBD is a [...]
A newly-obtained report by France’s Directorate General of Health (DGS) evaluating the impact of the medical cannabis pilot, recommended the roll out of a temporary regulatory framework last year. The Union of Industrialists for the Valorization of Hemp Extracts (UIVEC) in France says the report, dated [...]
Adolescents who use cannabis and report symptoms of psychosis may be self-medicating to alleviate those symptoms and the associated distress, according to the results of a new study. In the study, published in the journal JAMA Psychiatry, researchers analysed data from the Adolescent Brain Cognitive Development [...]
Representatives from five European countries, as well as the European Union Drug Agency (EUDA), met in Germany last week to discuss the regulation of cannabis for non-medical purposes. European leaders from Luxembourg, Malta, the Netherlands and Czech Republic attended an international ministerial exchange in Germany to [...]
Via Business of Cannabis Denmark’s six-year medical cannabis pilot scheme could soon be expanded into a fully legalised market, following a surprise announcement from the government last week. The Danish pilot scheme has been running since 2018, and has continued to expand in both scope and [...]
Men with a lifetime history of cannabis use experience “significantly less cognitive decline” over their lifetimes compared to non-users, according to new research. The study, published by a team of Danish researchers in the journal Brain and Behaviour, assessed the relationship between cannabis use and age-related [...]
Luxembourg is set to restrict access to high-THC cannabis flower on prescription from next year, as part of longer term plans to phase out flower-based products altogether. As of January 2025, patients in Luxembourg will no longer be able to access cannabis flower containing high levels [...]
New research has found no association between long-term cannabis use and cognitive decline in later life. Longitudinal data published in the journal Brain and Behavior, found no significant harmful effects of cannabis use on age-related cognitive decline. Researchers in Denmark examined the relationship between lifetime cannabis [...]
Via Business of Cannabis Mere hours after the results of the US election became clear, sending North American cannabis stocks into free fall, Germany’s ruling traffic light coalition all but collapsed, throwing the future of Europe’s largest and most promising cannabis market into uncertain territory. On [...]
Lifetime cannabis use is associated with several changes in brain structure and function in later life, suggests an observational study, but these associations may not be causal. This is according to researchers who conducted a genetic analysis of data from over 15,000 cannabis consumers in the [...]
The UK Government has announced a series of reforms to hemp licencing, making it easier for farmers to grow the crop. At present, anyone landowner or farmer wishing to grow hemp has to apply for a licence, outlining the specific fields they wish to use for [...]
A new study is the first to provide objective evidence that cannabinol (CBN) can improve sleep without any intoxicating effects. Research by scientists at the University of Sydney is the first to use objective measures to show the component, known as cannabinol (CBN), increases sleep in [...]
The legal dispensing of cannabis via a cultivation association has taken place for the first time in the German municipality of Ganderkesee. Cannabis Social Club Ganderkesee claims to be the first club in Germany to have carried out a legal cannabis harvest on behalf of members. [...]
Six years on from the legalisation of medical cannabis in the UK, families have made a fresh call for NHS access, as new figures reveal lack of prescribing. Families from across the UK returned to Westminster on Tuesday 5 November, clutching photos of their loved ones, [...]
A study led by Imperial College London will investigate if there is a role for psilocybin in the treatment of opioid addiction. It is reportedly the first time research involving psilocybin-assisted therapy to treat substance addiction will be financially backed by the UK Government. Despite the [...]
The Oireachtas Joint Committee on Drugs Use has published its interim report into the recommendations of Ireland’s landmark Citizens’ Assembly on Drugs Use, coming out strongly in favour of decriminalisation. Established earlier this year to further scrutinise the recommendations of the Citizens Assembly, the specialist committee was given until [...]
The NHS is not prescribing cannabis flower medication to any patients, including those with conditions such as epilepsy, chronic pain, and cancer, according to new research from the Cannabis Industry Council (CIC). Through a Freedom of Information (FoI) request, the CIC asked 152 NHS Foundation Trusts [...]
Six years ago today, the UK took a step forward, allowing eligible patients to access medical cannabis for chronic physical and mental health conditions. This November, we celebrate the anniversary of this landmark decision and reflect on the journey so far. Tens of thousands of patients [...]
New findings have identified a significant decline in the percentage of US adolescents reporting current cannabis use over the last decade. The study, published in the journal Pediatric Reports, reveals that in 2011, 23.1% of adolescents indicated they were current users, but by 2021, this figure [...]
A study into the ‘next day’ performance of people given an oil containing THC and CBD has found that cannabis has no significant impact on safety-sensitive tasks such as driving a vehicle. Cannabis, specifically the THC contained within, is well known to produce an effect on [...]
Events will take place at several major cities around the UK to raise awareness and bring medical cannabis education directly to the public. Patient advocates will visit Belfast, Birmingham, Glasgow, Cardiff and London throughout Medical Cannabis Awareness Week (1-7 November), to share their personal experiences and [...]
A parliamentary committee has recommended that cannabis should be partially legalised and accessed through social clubs in Ireland. The committee, set up to guide Ireland’s future drug legislation, said that personal possession of all drugs should be decriminalised and the country’s approach to drug use should [...]
A message from Dr Simon Erridge, Research Director at Curaleaf Clinic At Curaleaf Clinic, we’re committed to providing the highest standard of medical cannabis care, guided by science. As such, we are concerned about the growing number of people buying cannabis from illegal sources, including online [...]
Approaching the sixth anniversary of the legalisation of medical cannabis in the UK, private prescriptions are on the rise, but broader awareness among professionals and the public still lags behind. After almost six years of medical cannabis being available on prescription in the UK, the numbers [...]
Prescribing medical cannabis for chronic pain could save the NHS almost £4 billion annually, according to new research. The findings come from an independent economic analysis of medical cannabis for the treatment of chronic pain, undertaken by York Health-Economics Consortium at the University of York. Researchers [...]
Increasing access to medical cannabis on the NHS for chronic pain could save the state healthcare provider almost £4 billion annually, according to a new research study published by the Cannabis Industry Council (CIC). The study, published in the peer-reviewed journal Expert Review of Pharmacoeconomics & [...]
The majority of doctors in Germany can now prescribe medical cannabis for reimbursement without securing prior approval of the health insurance companies. It comes amid reports suggesting the German pharmacies are now key beneficiaries of the medical cannabis market, bringing in tens of thousands of euros [...]
A study by researchers at Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center (BMC) has found that cannabis use among young adults in the country of Georgia did not increase following legalisation. The use of cannabis was legalised for adults over the [...]
A study has found that a single high dose of psilocybin can lead to physical changes in the human brain. The study, which is in pre-print and has not yet been peer-reviewed, involved 28 healthy participants who had no prior experience with psilocybin or other psychedelics. [...]
The Cannabis Industry Council (CIC) has published a good practice guide for prescription cannabis clinics in the UK. The guidance includes 10 principles of good practice and five specific policies for clinics to implement. The good practice guide encourages ethical and responsible operations, builds industry collaboration, [...]
UK medical cannabis experts have published a comprehensive review of evidence for the prescription of cannabis-based medicines in epilepsy. With over 280 references to peer-reviewed literature, Medical Cannabis & Epilepsy, published by Maple Tree Consultants, provides the first review of nearly 100 clinical trials, real-world studies, and [...]
Berlin, Germany – 16 October, 2024 – Following the adoption of the CanG and the associated MedCanG Act, the German medical cannabis market is witnessing significant growth, with German medical cannabis sales expected to reach €420 million in 2024, rising to over €1 billion by 2028. [...]
By Sarah Sinclair with additional reporting from Ben Stevens (Business of Cannabis) Researchers say they are working to get two long-awaited NHS clinical trials underway to investigate the role of cannabis-based medicines in severe forms of epilepsy. The first significant update on the trials—first promised in [...]
The number of items prescribed in the UK’s private medical cannabis market has doubled each year since 2021, as the market continues its rapid expansion. According to the latest figures from the NHS Business Services Authority (NHSBSA), published in response to an FOI request, the number of [...]
A study, published in the Journal of Cannabis Research, has found that the legalisation of cannabis is linked with higher levels of physical activity. In the study, researchers from Brigham Young University used data from the Behavior Risk Factor Surveillance System (BRFSS) to evaluate the association between [...]
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
